Medicines and
Health Technologies

The main goal of the ​​Medicines and Health Technologies area is to strengthen the region’s medicines policy, developing strategies, together with different actors and organizations, that ensure the access to essential medicines and the sustainability of health systems.

 

With the creation of the South American Health Council, the universal access to medicines policy was incorporated into the agenda for South American health (Decision CJEG 12/2008). Several advances have been made regarding the implementation of this regional policy, including: the UNASUR Medicine Price Bank; the regional approach on the shortage of essential medicines; and the characterization of public procurement processes, among others.

 

With regard to the study of public procurement processes for medicines that describe the current situation for South American countries, one particular finding prioritized the setting of referential prices of medicines as an indispensable tool before starting an acquisition process. Currently nine countries apply this model.

 

The setting of reference prices requires a wide recognition of information sources, in this respect the availability of public information on the sanitary, therapeutic and financial situation of medicines is strategic, as well as the development of transparent technological platforms that shield important processes such as the acquisition of medicines.

 

Below are some information portals on medicines available for consultation in South American countries:

 

-Public procurement of essential medicines

-Pricing policies

-Medicines agencies

-Health Technologies Assessment

Work Topics

 

– Intellectual property

– Drug prices

– Health technology assessment

 

Angela Acosta

Angela Acosta

Graduated in Chemistry-Pharmacy from the National University of Colombia, she holds a Master’s Degree in Clinical and Sanitary Effectiveness from the University of Buenos Aires and holds a PhD in Pharmaceutical Sciences with emphasis in Pharmaceutical-epidemiology from the same institution. With 15 years’ experience, he has been a leader and advisor at the Ministry of Health and Social Protection of Colombia, at INVIMA (National Institute for Drug and Food Surveillance) and several projects for PAHO/WHO and the World Bank.

News

18/09/2018

Universal Access to Essential Medicines: Recent South American Experiences and Challenges for the Region

        Health as a fundamental right and regional integration are part of the welfare goals agreed upon by all countries in South America. Although we have some achievements in access to medicines, it is a priority to seek and promote regional access scenarios that do not violate the precepts of essentiality and […]

09/01/2018

The Mapping of Productive Capacity of Medicines and Health Supplies of the South American Region was launched

As the Executing Entity of the project, ISAGS will support GAUMU for the successful implementation of the project, which is of great relevance to the South American region in its drive to count as Universal Health Systems, recognizing health as a fundamental right of its population.

06/01/2018

Regulation of Prices of Medicines in South America: Results and Concrete Strategies of Colombia

In general, medicines are an important component of health spending. Data on total pharmaceutical expenditure confirms that medicines have an important share in the total health expenditure, while this proportion varies considerably between low- and high-income countries, from a 19.7% participation in high income countries to a 30.4% in low-income countries (WHO 2011). The pharmaceutical […]

02/01/2018

The 2018 Annual Operative Plan of ISAGS is under way

Every year, ISAGS submits to its Directing Council the work proposals for the following year. It’s the so-called Annual Operative Plan (POA 2018), which gathers and systematizes the main initiatives that will be carried out by the Institute’s different areas of action. “After an excellent year of activities and a good regional positioning in 2017, […]

04/12/2017

The Shadow of Monopolies in the Pharmaceutical Industry

How anti-competitive practices ensure exorbitant profits while limiting the ability of Health Systems to save lives In the annals of liberal economic theories, competition stands out as a fundamental aspect to the functioning of capitalism. In its perfect version, the market would be made up of multiple consumers and multiple producers (aggregate demand and aggregate […]

02/11/2017

Judicialization of medicines: right to health or symptoms of weaknesses in our systems?

Despite posing complex challenges, the principle that health is a fundamental right has guided the work of the South American regional health integration. How can these universal health systems be sustainable? Although UNASUR Member States have achievements towards the universal access to medicines at regional level, they face a vulnerable situation at certain occasions. Particularly, […]